200,000+ products from a single source!

sales@angenechem.com

Home > Oxazole > 82357-80-0

82357-80-0

82357-80-0 | 5-Isoxazolol

CAS No: 82357-80-0 Catalog No: AG008KG9 MDL No:

Product Description

Catalog Number:
AG008KG9
Chemical Name:
5-Isoxazolol
CAS Number:
82357-80-0
Molecular Formula:
C3H3NO2
Molecular Weight:
85.0614
IUPAC Name:
2H-1,2-oxazol-5-one
InChI:
InChI=1S/C3H3NO2/c5-3-1-2-4-6-3/h1-2,4H
InChI Key:
HZVPJXOQDCOJRJ-UHFFFAOYSA-N
SMILES:
Oc1ccno1

Properties

Complexity:
97  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
85.016g/mol
Formal Charge:
0
Heavy Atom Count:
6  
Hydrogen Bond Acceptor Count:
3  
Hydrogen Bond Donor Count:
1  
Isotope Atom Count:
0
Molecular Weight:
85.062g/mol
Monoisotopic Mass:
85.016g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
38.3A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.3  

Literature

Title Journal
Identification of novel small molecule inhibitors of 4-diphosphocytidyl-2-C-methyl-D-erythritol (CDP-ME) kinase of Gram-negative bacteria. Bioorganic & medicinal chemistry 20111001
Isoxazol-5(4H)one derivatives as PTP1B inhibitors showing an anti-obesity effect. Chemistry, an Asian journal 20110801
Click-generated triazole ureas as ultrapotent in vivo-active serine hydrolase inhibitors. Nature chemical biology 20110701
(Z)-4-[4-(Dimethyl-amino)benzyl-idene]-3-methyl-isoxazol-5(4H)-one. Acta crystallographica. Section E, Structure reports online 20091201
Facile synthesis of active antitubercular, cytotoxic and antibacterial agents: a Michael addition approach. European journal of medicinal chemistry 20051101
In vitro SAR of (5-(2H)-isoxazolonyl) ureas, potent inhibitors of hormone-sensitive lipase. Bioorganic & medicinal chemistry letters 20040621
Enzymatic synthesis of two isoxazolylalanine isomers by cysteine synthases in Lathyrus species. Biological & pharmaceutical bulletin 19960901

Related Products

© 2019 Angene International Limited. All rights Reserved.